Cargando…

Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus

Detalles Bibliográficos
Autores principales:	Kotyla, Przemysław, Olesińska, Marzena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253874/ https://www.ncbi.nlm.nih.gov/pubmed/37298420 http://dx.doi.org/10.3390/ijms24119470

Ejemplares similares

Quality of life in systemic lupus erythematosus and its measurement
por: Olesińska, Marzena, et al.
Publicado: (2018)

Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus
por: Kotyla, Przemysław, et al.
Publicado: (2022)

Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis
por: Garelli, Colton J., et al.
Publicado: (2020)

Psychological Implications to the Therapy of Systemic Lupus Erythematosus
por: Warchoł-Biedermann, Katarzyna, et al.
Publicado: (2022)

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis
por: Gumkowska-Sroka, Olga, et al.
Publicado: (2023)

Understanding Ocular Findings and Manifestations of Systemic Lupus Erythematosus: Update Review of the Literature
por: Luboń, Wojciech, et al.
Publicado: (2022)

Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review
por: Islam, Md Asiful, et al.
Publicado: (2020)

Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy
por: Shimizu, Yukihiro
Publicado: (2020)

Are Toll-Like Receptors and Decoy Receptors Involved in the Immunopathogenesis of Systemic Lupus Erythematosus and Lupus-Like Syndromes?
por: Guggino, Giuliana, et al.
Publicado: (2012)

Investigating the Role of T-bet(+) B Cells (ABCs/DN) in the Immunopathogenesis of Systemic Lupus Erythematosus
por: Sachinidis, Athanasios, et al.
Publicado: (2023)

Contribution of STAT4 gene single-nucleotide polymorphism to systemic lupus erythematosus in the Polish population
por: Piotrowski, Piotr, et al.
Publicado: (2012)

Contribution of toll-like receptor 9 gene single-nucleotide polymorphism to systemic lupus erythematosus
por: Piotrowski, Piotr, et al.
Publicado: (2012)

Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome
por: Haładyj, Ewa, et al.
Publicado: (2016)

Systemic Lupus Erythematosus
por: Putterman, Chaim, et al.
Publicado: (2012)

Systemic Lupus Erythematosus
por: Okamoto, Hiroshi, et al.
Publicado: (2012)

B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab
por: Wiesik-Szewczyk, E, et al.
Publicado: (2012)

Cytokines in Systemic Lupus Erythematosus
por: Poole, Brian D., et al.
Publicado: (2010)

Systemic Lupus Erythematosus 2014
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus
por: Mostowska, Adrianna, et al.
Publicado: (2012)

Cytokines in Systemic Lupus Erythematosus 2011
por: Poole, Brian D., et al.
Publicado: (2012)

Immunopathogenesis of environmentally induced lupus in mice.
por: Shaheen, V M, et al.
Publicado: (1999)

Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19
por: Chatterjee, Swapan K., et al.
Publicado: (2020)

Systemic Lupus Erythematosus: Genomics, Mechanisms, and Therapies
por: Fernández-Nebro, Antonio, et al.
Publicado: (2012)

Molecular Insights into Systemic Lupus Erythematosus Pathogenesis
por: Laxminarayana, Dama
Publicado: (2014)

An era of biological treatment in systemic lupus erythematosus
por: He, Jing, et al.
Publicado: (2017)

MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis
por: Chafin, Cristen B., et al.
Publicado: (2013)

Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies
por: Pan, Quanren, et al.
Publicado: (2021)

Novel therapeutic agents in clinical development for systemic lupus erythematosus
por: Jordan, Natasha, et al.
Publicado: (2013)

To target or not to target APRIL in systemic lupus erythematosus: that is the question!
por: Morel, Jacques, et al.
Publicado: (2013)

Adhesion molecules: a way to understand lupus
por: Nowak, Karolina, et al.
Publicado: (2022)

Editorial: Cutting edge in systemic lupus erythematosus
por: D’Cruz, David P., et al.
Publicado: (2017)

The Role of MECP2 and CCR5 Polymorphisms on the Development and Course of Systemic Lupus Erythematosus
por: Rzeszotarska, Ewa, et al.
Publicado: (2020)

Systemic lupus erythematosus of the urinary tract: focus on lupus cystitis
por: Liberski, Sławomir, et al.
Publicado: (2018)

Systemic lupus erythematosus and its ABCs (APRIL/BLyS complexes)
por: Stohl, William
Publicado: (2010)

Autoimmunity induced by human cytomegalovirus in patients with systemic lupus erythematosus
por: Söderberg-Nauclér, Cecilia
Publicado: (2012)

Advances in Systemic Lupus Erythematosus (SLE): A case for optimism
por: Fanouriakis, Antonis, et al.
Publicado: (2017)

Therapeutic inhibition of proteasomes in systemic lupus erythematosus
por: Hiepe, Falk, et al.
Publicado: (2011)

Genome-wide association studies in systemic lupus erythematosus: a perspective
por: Cunninghame Graham, Deborah S
Publicado: (2009)

Preventive health services for systemic lupus erythematosus patients: whose job is it?
por: Burgos, Paula I, et al.
Publicado: (2010)

Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
por: Ding, Shu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_76idsr4qqavnhrqrql3mhg34gk